Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-03

Clinical Trial Update: Atlantic Lipid Lowering Treatment Optimization Program [NA]

View source ↗

Summary

Clinical Trial Update for the Atlantic Lipid Lowering Treatment Optimization Program (NCT06439654) shows recruiting status for multiple lipid disorders includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Atlantic Health System | Conditions: Familial Hypercholesterolemia, Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia | NA | Status: RECRUITING